Target choice and exon skipping regulate CRISPR-directed gene editing of NRF2 in head/neck and esophageal cancer cells

Authors: Rivera-Torres N, Skelly LE, Rogowskyj JA, Aguilar G, Banas, K, Bialk, P, Kmiec EB

Journal: Molecular Therapy Oncology, 2026

Functional characterization of tumor-specific CRISPR-directed gene editing as a combinatorial therapy for the treatment of solid tumors
Authors: Banas KH, Bialk PA, Rivera-Torres N, Owens, K, Reiner, TN, Pisarcik, KM Haas, N, Gielda, E, Khan, K, Narra, KP, Kmiec EB

Journal: Molecular Therapy Oncology, 2025

CRISPR gene editing: Can we make cancer cells easier to kill?

Author: Eric B. Kmiec

Journal: Research Outreach (Page 62) 2024

CRISPR-Directed Gene Editing as a Method to Reduce Chemoresistance in Lung Cancer Cells

Authors: Rivera-Torres N, Bialk P, Kmiec EB

Book: Cancer Systems and Integrative Biology, 2023

Exon skipping induced by CRISPR-directed gene editing regulates the response to chemotherapy in non-small cell lung carcinoma cells

Authors: Banas K, Modarai S, Rivera-Torres N, Yoo B-C, Bialk P, Barrett C, Batish M, Kmiec EB
Journal: Gene Therapy, 2022

Potential Inequities in New Medical Technologies
Authors: Kmiec EB, Marron J
Journal: Scientific American, 2020

Kinetics of Nuclear Uptake and Site-Specific DNA Cleavage during CRISPR-Directed Gene Editing in Solid Tumor Cells

Authors: Banas K, Rivera-Torres N, Bialk P, Yoo BC, Kmiec EB
Journal: Molecular Cancer Research, 2020

Functional Gene Knockout of NRF2 Increases Chemosensitivity of Human Lung Cancer A549 Cells in Vitro and in Xenograft Mouse Model

Authors: Bialk P, Wang Y, Banas K, Kmiec EB
Journal: Molecular Therapy Oncolytics, 2018